blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2776464

EP2776464 - ANTIBODY SPECIFIC FOR TRANS-RESVERATROL AND USE THEREOF [Right-click to bookmark this link]
Former [2014/38]ANTIBODY SPECIFIC FOR TRANS - RESVERATROL AND USE THEREOF
[2016/19]
StatusNo opposition filed within time limit
Status updated on  04.08.2017
Database last updated on 25.09.2024
Most recent event   Tooltip19.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 21.11.2018  [2018/47]
Applicant(s)For all designated states
IP Science Limited
2nd Floor The Platinum Building
St. John's Innovation Park
Cowley Road
Cambridge CB4 0DS / GB
[2016/23]
Former [2014/38]For all designated states
IP Science Limited
2nd Floor The Platinum Building
St. John's Innovation Park
Cowley Road
Cambridge CB5 0DS / GB
Inventor(s)01 / PETYAEV, Ivan
1 Cambridge Road
Coton
Cambridge CB23 7PJ / GB
02 / TSYBEZOV, Valery
Ap.130 3 building 2
800 let Moskvy
Moscow 127591 / RU
 [2014/38]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2014/38]Power, David
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date12787064.009.11.2012
[2016/39]
WO2012GB52790
Priority number, dateGB2011001958511.11.2011         Original published format: GB 201119585
[2014/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013068758
Date:16.05.2013
Language:EN
[2013/20]
Type: A1 Application with search report 
No.:EP2776464
Date:17.09.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 16.05.2013 takes the place of the publication of the European patent application.
[2014/38]
Type: B1 Patent specification 
No.:EP2776464
Date:28.09.2016
Language:EN
[2016/39]
Search report(s)International search report - published on:EP16.05.2013
ClassificationIPC:C07K16/14, G01N33/53
[2014/38]
CPC:
C07K16/14 (EP,US); C07K16/44 (EP,US); G01N33/5308 (EP,US);
G01N33/74 (EP,US); G01N33/94 (EP,US); A61K39/39583 (EP,US);
C07K2317/14 (US); C07K2317/30 (US); G01N2430/00 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/38]
Extension statesBA09.06.2014
ME09.06.2014
TitleGerman:TRANSRESVERATROL-SPEZIFISCHE ANTIKÖRPER UND VERWENDUNGEN DAVON[2014/38]
English:ANTIBODY SPECIFIC FOR TRANS-RESVERATROL AND USE THEREOF[2016/19]
French:ANTICORPS SPÉCIFIQUE POUR LE TRANS-RESVÉRATROL ET SON UTILISATION[2014/38]
Former [2014/38]ANTIBODY SPECIFIC FOR TRANS - RESVERATROL AND USE THEREOF
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase09.06.2014National basic fee paid 
09.06.2014Designation fee(s) paid 
09.06.2014Examination fee paid 
Examination procedure09.06.2014Amendment by applicant (claims and/or description)
09.06.2014Examination requested  [2014/38]
12.08.2015Despatch of a communication from the examining division (Time limit: M04)
23.11.2015Reply to a communication from the examining division
25.04.2016Communication of intention to grant the patent
22.08.2016Fee for grant paid
22.08.2016Fee for publishing/printing paid
22.08.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.08.2015
Opposition(s)29.06.2017No opposition filed within time limit [2017/36]
Fees paidRenewal fee
10.11.2014Renewal fee patent year 03
10.11.2015Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.11.2012
AL28.09.2016
AT28.09.2016
BE28.09.2016
CY28.09.2016
CZ28.09.2016
DK28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
MC28.09.2016
MK28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SI28.09.2016
SK28.09.2016
SM28.09.2016
TR28.09.2016
MT09.11.2016
LU30.11.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
[2018/47]
Former [2018/45]HU09.11.2012
AT28.09.2016
BE28.09.2016
CY28.09.2016
CZ28.09.2016
DK28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
MC28.09.2016
MK28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SI28.09.2016
SK28.09.2016
SM28.09.2016
TR28.09.2016
MT09.11.2016
LU30.11.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
Former [2018/43]HU09.11.2012
AT28.09.2016
BE28.09.2016
CY28.09.2016
CZ28.09.2016
DK28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
MC28.09.2016
MK28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SI28.09.2016
SK28.09.2016
SM28.09.2016
MT09.11.2016
LU30.11.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
Former [2018/30]HU09.11.2012
AT28.09.2016
BE28.09.2016
CY28.09.2016
CZ28.09.2016
DK28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
MC28.09.2016
MK28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SI28.09.2016
SK28.09.2016
SM28.09.2016
LU30.11.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
Former [2017/52]AT28.09.2016
BE28.09.2016
CZ28.09.2016
DK28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SI28.09.2016
SK28.09.2016
SM28.09.2016
LU30.11.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
Former [2017/48]AT28.09.2016
BE28.09.2016
CZ28.09.2016
DK28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SK28.09.2016
SM28.09.2016
LU30.11.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
Former [2017/34]AT28.09.2016
BE28.09.2016
CZ28.09.2016
DK28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SK28.09.2016
SM28.09.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
Former [2017/23]AT28.09.2016
BE28.09.2016
CZ28.09.2016
EE28.09.2016
ES28.09.2016
FI28.09.2016
HR28.09.2016
IT28.09.2016
LT28.09.2016
LV28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SK28.09.2016
SM28.09.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
PT30.01.2017
Former [2017/23]AT28.09.2016
BE28.09.2016
CZ28.09.2016
EE28.09.2016
FI28.09.2016
HR28.09.2016
LT28.09.2016
LV28.09.2016
NL28.09.2016
PL28.09.2016
RO28.09.2016
RS28.09.2016
SE28.09.2016
SK28.09.2016
BG28.12.2016
NO28.12.2016
GR29.12.2016
IS28.01.2017
Former [2017/13]FI28.09.2016
HR28.09.2016
LT28.09.2016
LV28.09.2016
NL28.09.2016
RS28.09.2016
SE28.09.2016
BE30.11.2016
NO28.12.2016
GR29.12.2016
Former [2017/11]FI28.09.2016
HR28.09.2016
LT28.09.2016
RS28.09.2016
SE28.09.2016
BE30.11.2016
NO28.12.2016
GR29.12.2016
Former [2017/10]FI28.09.2016
HR28.09.2016
LT28.09.2016
RS28.09.2016
SE28.09.2016
BE30.11.2016
NO28.12.2016
Former [2017/09]FI28.09.2016
LT28.09.2016
NO28.12.2016
Former [2017/07]LT28.09.2016
Cited inInternational search[I]RU2385457  (G OBRAZOVATEL NOE UCHREZHDENIE [RU]) [I] 1-11 * the whole document *;
 [I]  - LUÍSA PAULO ET AL, "Development and Validation of an Analytical Method for the Determination of trans - and cis -Resveratrol in Wine: Analysis of Its Contents in 186 Portuguese Red Wines", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, (20110323), vol. 59, no. 6, doi:10.1021/jf105004y, ISSN 0021-8561, pages 2157 - 2168, XP055055189 [I] 1-11 * abstract * * page 2157, column l, paragraph 1 - column r, paragraph 3 *

DOI:   http://dx.doi.org/10.1021/jf105004y
 [I]  - HE H ET AL, "High-performance liquid chromatography spectrometric analysis of trans-resveratrol in rat plasma", JOURNAL OF CHROMATOGRAPHY B: BIOMEDICAL SCIENCES & APPLICATIONS, ELSEVIER, AMSTERDAM, NL, vol. 832, no. 2, ISSN 1570-0232, (20060307), pages 177 - 180, (20060307), XP027982135 [I] 1-11 * abstract *
 [A]  - CHAPPEY O N ET AL, "MONOCLONAL ANTIBODIES IN HAPTEN IMMUNOASSAYS", PHARMACEUTICAL RESEARCH, KLUWER ACADEMIC PUBLISHERS, NEW YORK, NY, US, (19921101), vol. 9, no. 11, doi:10.1023/A:1015890208714, ISSN 0724-8741, pages 1375 - 1379, XP008005000 [A] 1-11 * the whole document *

DOI:   http://dx.doi.org/10.1023/A:1015890208714
 [A]  - ZHANG H ET AL, "Review on enzyme-linked immunosorbent assays for sulfonamide residues in edible animal products", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 350, no. 1-2, doi:10.1016/J.JIM.2009.07.006, ISSN 0022-1759, (20091031), pages 1 - 13, (20090728), XP026684055 [A] 1-11 * page 5, column l, paragraph 3 - column r, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/j.jim.2009.07.006
 [A]  - YAU K Y F ET AL, "Emerging trends in the synthesis and improvement of hapten-specific recombinant antibodies", BIOTECHNOLOGY ADVANCES, ELSEVIER PUBLISHING, BARKING, GB, (20031001), vol. 21, no. 7, doi:10.1016/S0734-9750(03)00104-6, ISSN 0734-9750, pages 599 - 637, XP004458524 [A] 1-11 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0734-9750(03)00104-6
by applicant   - DEVEREUX ET AL., NUCLEIC ACIDS RESEARCH, (1984), vol. 12, pages 387 - 395
    - ALTSCHUL S. F., J MOL EVOL, (1993), vol. 36, pages 290 - 300
    - ALTSCHUL, S, F ET AL., J MOL BIOL, (1990), vol. 215, pages 403 - 10
    - HENIKOFFAND HENIKOFF, PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 10915 - 10919
    - KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 5873 - 5787
    - Y.L. JIANG ET AL., BIOORG MED CHERN., (2008), vol. 16, no. 12, pages 6406 - 14
    - SOUKPOE-KOSSI, BIOMOL STRUCT DYN., (2006), vol. 24, no. 3, pages 277 - 83
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.